Dr. Dan Byrom

Dr. Dan Byrom is an experienced professional in business development and sales within the pharmaceutical sector, currently serving as the Director of Business Development for the API Portfolio at Siegfried Holding AG since September 2022. Prior to this role, Dan held the position of Area Sales Manager at UQUIFA, focusing on the sales of a full portfolio of APIs in Europe, and at IMCD Group, which followed an acquisition of DCS Pharma AG. Dan's career began at Enantia, S.L. as an Account Manager, and prior academic experience includes a PhD at IRB Barcelona, where research involved the scale-up of P-chiral phosphine ligands for asymmetric catalysis. Dan holds a Master of Research in Green Chemistry from Imperial College London and a Bachelor of Science in Chemistry from Newcastle University.